Sökning: WFRF:(Storgaard Merete) > Population Pharmaco...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 03855naa a2200457 4500 | |
001 | oai:DiVA.org:uu-408727 | |
003 | SwePub | |
008 | 200413s2020 | |||||||||||000 ||eng| | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-4087272 URI |
024 | 7 | a https://doi.org/10.1128/AAC.02556-192 DOI |
040 | a (SwePub)uu | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Klastrup, Vibeke4 aut |
245 | 1 0 | a Population Pharmacokinetics of Piperacillin following Continuous Infusion in Critically Ill Patients and Impact of Renal Function on Target Attainment |
264 | 1 | c 2020 |
338 | a print2 rdacarrier | |
500 | a Title in thesis list of papers: Population pharmacokinetics of piperacillin following continuous infusion in critically ill patients: Impact of renal function on target attainment | |
520 | a Pharmacokinetic changes are often seen in patients with severe infections. Administration by continuous infusion has been suggested to optimize antibiotic exposure and pharmacokinetic/pharmacodynamic (PK/PD) target attainment for β-lactams. In an observational study, unbound piperacillin concentrations (n = 196) were assessed in 78 critically ill patients following continuous infusion of piperacillin-tazobactam (ratio 8:1). The initial dose of 8, 12, or 16 g (piperacillin component) was determined by individual creatinine clearance (CRCL). Piperacillin concentrations were compared to the EUCAST clinical breakpoint MIC for Pseudomonas aeruginosa (16 mg/liter), and the following PK/PD targets were evaluated: 100% free time (fT) > 1× MIC and 100% fT > 4× MIC. A population pharmacokinetic model was developed using NONMEM 7.4.3 consisting of a one-compartment disposition model with linear elimination separated into nonrenal and renal (linearly increasing with patient CRCL) clearances. Target attainment was predicted and visualized for all individuals based on the utilized CRCL dosing algorithm. The target of 100% fT > 1× MIC was achieved for all patients based on the administered dose, but few patients achieved the target of 100% fT > 4× MIC. Probability of target attainment for a simulated cohort of patients showed that increasing the daily dose by 4-g increments (piperacillin component) did not result in substantially improved target attainment for the 100% fT > 4× MIC target. To conclude, in patients with high CRCL combined with high-MIC bacterial infections, even a continuous infusion (CI) regimen with a daily dose of 24 g may be insufficient to achieve therapeutic concentrations. | |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Infektionsmedicin0 (SwePub)302092 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Infectious Medicine0 (SwePub)302092 hsv//eng |
653 | a beta-lactam antibiotic | |
653 | a continuous infusion | |
653 | a critically ill | |
653 | a pharmacokinetics | |
653 | a piperacillin | |
653 | a Farmaceutisk farmakologi | |
653 | a Pharmaceutical Pharmacology | |
653 | a Klinisk farmakologi | |
653 | a Clinical Pharmacology | |
700 | 1 | a Thorsted, Andersu Uppsala universitet,Institutionen för farmaceutisk biovetenskap4 aut0 (Swepub:uu)andth549 |
700 | 1 | a Storgaard, Merete4 aut |
700 | 1 | a Christensen, Steffen4 aut |
700 | 1 | a Friberg, Lenau Uppsala universitet,Institutionen för farmaceutisk biovetenskap4 aut0 (Swepub:uu)lenasimo |
700 | 1 | a Öbrink-Hansen, Kristina4 aut |
710 | 2 | a Uppsala universitetb Institutionen för farmaceutisk biovetenskap4 org |
773 | 0 | t Antimicrobial Agents and Chemotherapyg 64:7q 64:7x 0066-4804x 1098-6596 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-408727 |
856 | 4 8 | u https://doi.org/10.1128/AAC.02556-19 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy